<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/135913</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Biophysics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Millisecond dynamics of BTK reveal kinome-wide conformational plasticity within the apo kinase domain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sultan</surname>
<given-names>Mohammad M.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Denny</surname>
<given-names>Rajiah Aldrin</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n2">&#x0023;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Unwalla</surname>
<given-names>Ray</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lovering</surname>
<given-names>Frank</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pande</surname>
<given-names>Vijay S.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">&#x2020;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Chemistry, Stanford University</institution>, 318 Campus Drive, Stanford, California 94305, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Medicine Design, Worldwide Research &#x0026; Development</institution>, Pfizer Inc, 610 Main St, Cambridge, MA 02139, <country>USA</country></aff>
</contrib-group>
<author-notes>
<fn id="n1"><label>&#x2020;</label><p><email>Pande@stanford.edu</email></p></fn>
<fn id="n2"><label>&#x0023;</label><p><email>Aldrin.Denny@pfizer.com</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<year>2017</year>
</pub-date>
<elocation-id>135913</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="135913.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Bruton tyrosine kinase (BTK) is a key enzyme in B-cell development whose improper regulation causes severe immunodeficiency diseases. Design of selective BTK therapeutics would benefit from improved, <italic>in-silico</italic> structural modeling of the kinase&#x2019;s solution ensemble. However, this remains challenging due to the immense computational cost of sampling events on biological timescales. In this work, we combine multi-millisecond molecular dynamics (MD) simulations with Markov state models (MSMs) to report on the thermodynamics, kinetics, and accessible states of BTK&#x2019;s kinase domain. Our conformational landscape links the active state to several inactive states, connected via a structurally diverse intermediate. Our calculations predict a kinome-wide conformational plasticity, and indicate the presence of several new potentially druggable BTK states. We further find that the population of these states and the kinetics of their inter-conversion are modulated by protonation of an aspartate residue, establishing the power of MD &#x0026; MSMs in predicting effects of chemical perturbations.</p>
</abstract>
<counts>
<page-count count="17"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Protein kinases are regulators of biochemical pathways in eukaryotic cells<sup><xref rid="c1" ref-type="bibr">1</xref>&#x2013;<xref rid="c3" ref-type="bibr">3</xref></sup> responsible for initializing and controlling signaling cascades<sup><xref rid="c3" ref-type="bibr">3</xref>,<xref rid="c4" ref-type="bibr">4</xref></sup> by catalyzing the transfer of ATP&#x2019;s gamma phosphate group to target residues on other enzymes. Given their critical involvement in cellular processes, their functionality is tightly controlled through a combination of regulatory domains<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c5" ref-type="bibr">5</xref>,<xref rid="c6" ref-type="bibr">6</xref></sup> and post-translational modificiations<sup><xref rid="c3" ref-type="bibr">3</xref></sup> that modulate their multi-state behavior<sup><xref rid="c1" ref-type="bibr">1</xref>,<xref rid="c6" ref-type="bibr">6</xref>&#x2013;<xref rid="c9" ref-type="bibr">9</xref></sup>. Sequence mutations, truncations, and over-expression of various kinases have been phenotypically linked to various cancers<sup><xref rid="c3" ref-type="bibr">3</xref>,<xref rid="c4" ref-type="bibr">4</xref>,<xref rid="c10" ref-type="bibr">10</xref></sup> and other diseases<sup><xref rid="c11" ref-type="bibr">11</xref></sup>.</p>
<p>Bruton tyrosine kinase (BTK)<sup><xref rid="c12" ref-type="bibr">12</xref>&#x2013;<xref rid="c15" ref-type="bibr">15</xref></sup>, part of the TEC family of kinases, is involved in T-cell and B-cell development. In humans, poor B-cell maturation leads to severe immune deficiencies, including increased susceptibility to bacterial infections<sup><xref rid="c16" ref-type="bibr">16</xref></sup>. Therefore, BTK&#x2019;s catalytic domain is a pharmaceutical target with several inhibitors, including FDA-approved drugs<sup><xref rid="c17" ref-type="bibr">17</xref></sup>. Similar to other kinases, BTK&#x2019;s catalytic domain (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) is bi-lobal with a &#x03B2;-sheet heavy N-lobe and a &#x03B1;-helical C-lobe. ATP and magnesium ions bind in the active site between the two lobes (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). The activation loop (A-loop, <xref ref-type="fig" rid="fig1">Figure 1a</xref>, red) connects the two lobes and modulates substrate binding. Phosphorylation of Tyr551 at the C-terminal end of the A-loop increases BTK&#x2019;s activity by ten fold<sup><xref rid="c15" ref-type="bibr">15</xref></sup>. The N-terminal end of the A-loop contains the highly conserved aspartate-phenylalanine-glycine motif (DFG, <xref ref-type="fig" rid="fig1">Figure 1b</xref>, blue) which samples several pharmacologically relevant states<sup><xref rid="c18" ref-type="bibr">18</xref></sup>. The aspartate of the DFG can be protonated<sup><xref rid="c9" ref-type="bibr">9</xref></sup>, modulating drug binding<sup><xref rid="c19" ref-type="bibr">19</xref></sup>. In the N-lobe, the glycine rich phosphate-positioning loop (P-loop, <xref ref-type="fig" rid="fig1">Figure 1a</xref>, green) helps to position ATP&#x2019;s gamma phosphate group. One &#x03B2;-sheet over, the N-lobe contains a conserved Lysine (Lys430, <xref ref-type="fig" rid="fig1">Figure 1b</xref>) that hydrogen bonds with ATP&#x2019;s &#x03B1;-phosphate group. The N-lobe also has the catalytic helix (C-helix, <xref ref-type="fig" rid="fig1">Figure 1b</xref>, orange) which contains a conserved Glutamate residue (Glu445, <xref ref-type="fig" rid="fig1">Figure 1b</xref>) that forms critical salt bridges to Lys430 in the active state and Arg544 in the inactive form.</p>
<fig id="fig1" position="float" fig-type="figure"><label>Figure 1:</label>
<caption><p><italic>BTK exists in several thermodynamically stable states. Within the MD ensemble, BTK catalytic domain samples several states, including (a) active (DFG</italic><sup><italic>in</italic></sup><italic>/C-helix</italic><sup><italic>in</italic></sup><italic>) (b), Src-like (A-loop folded/DFG</italic><sup><italic>in</italic></sup><italic>/C-helix</italic><sup><italic>out</italic></sup><italic>) (c) and DFG</italic><sup><italic>out</italic></sup> <italic>(d) within our simulation ensemble. The transition from active (a) to Src like (b) is defined by the outward rotation of the C-helix (orange) and folding of the A-loop (red). The C-helix rotation breaks a critical salt bridge between Glu445-Lys430 and forms salt bridges between Glu439-Arg468 (yellow) and Glu445-Arg544(orange). In the DFG</italic><sup><italic>out</italic></sup> <italic>state, Phe540(purple), part of the DFG motif (blue) rotates away from the core of the protein towards the ATP binding site. The R-spine (purple surface) forms continous hydorphobic contacts in the active state but is broken in the other states.</italic></p></caption>
<graphic xlink:href="135913_fig1.tif"/>
</fig>
<p>Crystallographic and biochemical studies on BTK<sup><xref rid="c13" ref-type="bibr">13</xref>&#x2013;<xref rid="c15" ref-type="bibr">15</xref></sup> and other kinases<sup><xref rid="c3" ref-type="bibr">3</xref>,<xref rid="c20" ref-type="bibr">20</xref></sup> have already provided a considerable amount of insight into their thermodynamically accessible enzymatic states. BTK can exist in active<sup><xref rid="c14" ref-type="bibr">14</xref></sup>, inactive<sup><xref rid="c21" ref-type="bibr">21</xref></sup>, and DFG out<sup><xref rid="c21" ref-type="bibr">21</xref></sup> states. In the putative active state (<xref ref-type="fig" rid="fig1">Figure 1b</xref>), the DFG-aspartate residue moves towards the ATP binding site (DFG<sup>in</sup>) to chelate magnesium; the C-helix rotates into the protein core (C-helix<sup>in</sup>)<sup><xref rid="c14" ref-type="bibr">14</xref></sup>; and the A-loop is unfolded and transiently samples a &#x03B2;-sheet secondary structure. In the DFG<sup>in</sup> inactive state, the C-helix rotates outwards (C-helix<sup>out</sup>), and the A-loop folds into a double helix (<xref ref-type="fig" rid="fig1">Figure 1c</xref>)<sup><xref rid="c14" ref-type="bibr">14</xref></sup>. We refer to this double helical inactive state as Src-like due to it topological similarity to the Src kinase&#x2019;s inactive state<sup><xref rid="c22" ref-type="bibr">22</xref></sup>. In the DFG<sup>out</sup> state, the DFG-Asp rotates towards the core of the protein (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, Supporting Table 1).</p>
<p>While the crystallographic coordinates for BTK provide us with structural insights, these models do not provide information about unrealized thermodynamically stable states or the pathways connecting them. Molecular dynamics (MD) is a computational modeling technique used to complement experimental work in biophysical systems. MD<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c9" ref-type="bibr">9</xref></sup> provides atomistic insight into complex processes, and has led to the proposal of several new kinase structural intermediates<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c23" ref-type="bibr">23</xref>&#x2013;<xref rid="c25" ref-type="bibr">25</xref></sup> and allosteric pathways<sup><xref rid="c8" ref-type="bibr">8</xref></sup>.</p>
<p>In this paper, we performed an aggregate of 1.7 milliseconds of MD simulations on the DFG-deprotonated (BTK-ASP) and DFG-protonated (BTK-ASH) forms of the unliganded BTK catalytic domain on the massively distributed Folding&#x0040;home<sup><xref rid="c26" ref-type="bibr">26</xref></sup> computing platform(see Methods for details regarding the homology modeling). The aggregate simulation times make this study three times longer than the largest reported MD results on kinases<sup><xref rid="c7" ref-type="bibr">7</xref></sup> and three orders of magnitude larger than any computational investigation into BTK&#x2019;s dynamics<sup><xref rid="c12" ref-type="bibr">12</xref>,<xref rid="c27" ref-type="bibr">27</xref></sup>. We characterized kinome-wide structural plasticity within the C-helix and DFG motifs, identifying a number of conformations as viable pharmaceutical targets. We used Markov state models<sup><xref rid="c28" ref-type="bibr">28</xref>,<xref rid="c29" ref-type="bibr">29</xref></sup> (MSMs) to gain atomistic insight into the thermodynamics and kinetics of BTK&#x2019;s conformational ensemble, identifying a structurally diverse intermediate state that links the active, Src-like, and DFG<sup>out</sup> states.</p>
<sec id="s1a">
<title>BTK kinase domain samples kinome-wide conformational space</title>
<p>We began our analysis by comparing the structural heterogeneity in the MD BTK-ASP dataset to the kinome-wide PDB classification of M&#x00F6;bitz et al<sup><xref rid="c18" ref-type="bibr">18</xref></sup> (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In that paper, the authors classified kinase structures along variations of the conserved DFG motif, the C-helix, and the A-loop. Starting from several publically available BTK protein coordinates (Supporting Table 2), our simulations capture kinome-wide crystallographically observed states that were previously stabilized via a combination of sequence, drugs, small peptides, and crystallographic conditions. For example, our simulations predict several configurations that M&#x00F6;bitz classified as the Imatinib, a leukemia drug, binding mode (Supporting Figure 3) for Abl kinase<sup><xref rid="c19" ref-type="bibr">19</xref>,<xref rid="c30" ref-type="bibr">30</xref>,<xref rid="c31" ref-type="bibr">31</xref></sup>. In this pose, the DFG-Phe540 residue (<xref ref-type="fig" rid="fig1">Figure 1d</xref>) rotates towards the ATP binding site (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), creating a back pocket capable of accepting an aromatic moiety. It is worth emphasizing that the A-loop (including DFG-Phe540) was not resolved in similar BTK<sup><xref rid="c21" ref-type="bibr">21</xref></sup> structures, creating difficulties for structure-based drug discovery. This result indicates the increasing ability of MD simulations to predict physiologically and pharmacologically relevant positioning of critical structural motifs. Intriguingly, BTK&#x2019;s plasticity supports the model that all kinases sample a single conformational landscape whose topology is modulated by their sequence and/or chemical environment.</p>
<fig id="fig2" position="float" fig-type="figure"><label>Figure 2:</label>
<caption><p><italic>BTK&#x2019;s apo domain contains kinome-wide conformational plasticity. Comparison of 9&#x0025; of MD generated structures (a) against publically available kinase domain structures (b) projected along three key degrees of freedom as outlined in M&#x00F6;bitz et al</italic><sup><xref rid="c18" ref-type="bibr">18</xref></sup>. <italic>We used the data and classification scheme provided in ref.</italic> 18 <italic>to generate (b). The top y-coordinate tracks the C-helix</italic><sup><italic>in</italic></sup> <italic>to C-helix</italic><sup><italic>out</italic></sup> <italic>transition while the bottom y-coordinate tracks the DFG</italic><sup><italic>in</italic></sup> <italic>to DFG</italic><sup><italic>out</italic></sup> <italic>transition. The common x-axis subdivides the conformations into pharmacologically relevant states of the DFG motif. The white circles in (a) correspond to the starting configurations for the MD simulations. The points are colored according to their M&#x00F6;bitz classification and detailed in Supporting Figure 16. For BTK&#x2019;s free energies along these coordinates, see Supporting Figure 9.</italic></p></caption>
<graphic xlink:href="135913_fig2.tif"/>
</fig>
</sec>
<sec id="s1b">
<title>BTK&#x2019;s apo domain is primarily inactive</title>
<p>To gain insight into the thermodynamics and kinetics of BTK, we built a statistically robust MSM for the hundreds of collected MD trajectories (Supporting Figure 1-2). Markov modeling<sup><xref rid="c28" ref-type="bibr">28</xref></sup> involves Voronoi partitioning of the accessible phase space into states and counting the transitions between the states. The metastable states are defined using a kinetically relevant distance metric (see Methods) that is learnt via sparse time structure-based independent component analysis (sparse-tICA)<sup><xref rid="c32" ref-type="bibr">32</xref>&#x2013;<xref rid="c35" ref-type="bibr">35</xref></sup>. tICA finds linear combinations of input MD features that de-correlate the slowest within the given dataset. The dominant components &#x2013; tICs &#x2013; relate the slow structural changes to long timescale protein dynamics. After performing this dimensionality reduction, we built an optimized<sup><xref rid="c36" ref-type="bibr">36</xref>,<xref rid="c37" ref-type="bibr">37</xref></sup> MSM (see Methods) whose transition matrix reflects the ensemble equilibrium populations and long timescale processes.</p>
<p>We projected the BTK-ASP and BTK-ASH MD ensembles onto the dominant tICs (<xref ref-type="fig" rid="fig3">Figure 3a</xref>) and several structural order parameters (Supporting Figure 9-11). These structural projections help us to understand the relative thermodynamic stability of various states as a function of the chosen order parameter. Our analysis indicates that the two principal tICs correspond to (1) the flipping of the DFG motif (Supporting Figure 6) and (2) the unfolding of the A-loop coupled with the rotation of the C-helix to the protein core, respectively (Supporting Figure 7). The free energy surface (<xref ref-type="fig" rid="fig3">Figure 3a</xref>) lets us define a four-state model (<xref ref-type="fig" rid="fig3">Figure 3b</xref>, Supporting Figure 8) in which a structurally heterogeneous intermediate hub (I<sub>1</sub>, Supporting Figure 5) controls access to active, Src-like, and DFG<sup>out</sup> states. This intermediate contains a partially or fully unfolded A-loop, DFG<sup>in</sup>, and C-helix<sup>out</sup>. Our simulations predict the Src-like state to be the most stable state of BTK-ASP (<xref ref-type="fig" rid="fig3">Figure 3a</xref>) with the active and DFG<sup>out</sup> states both being 1-2 kcal/mol above the minimum energy observed. Within the BTK-ASP model, these states (Supporting Figure 8, 10 &#x0026; 12) have populations of <inline-formula><alternatives><inline-graphic xlink:href="135913_inline1.gif"/></alternatives></inline-formula>, <inline-formula><alternatives><inline-graphic xlink:href="135913_inline2.gif"/></alternatives></inline-formula>, and <inline-formula><alternatives><inline-graphic xlink:href="135913_inline3.gif"/></alternatives></inline-formula> respectively. The sub-script and super-script indicate the 95&#x0025; confidence interval. See Supporting Figure 2 for the complete distribution. The rest of the population exists in the intermediate state. The low active state population lines up with the large number of inactive crystal structures (<xref ref-type="fig" rid="fig2">Figure 2a</xref>, dark magenta region), and biochemical studies showing that BTK&#x2019;s Tyr551&#x2019;s phosphorylation<sup><xref rid="c15" ref-type="bibr">15</xref></sup> is required for full activation. The number of minor and major populated states, and their micro to millisecond exchange timescales, are also consistent with NMR studies on other kinases. For example, the DFG-Phe in apo-p38a<sup><xref rid="c38" ref-type="bibr">38</xref></sup> is unobserved in NMR due to line broadening, attributed to DFG-flip conformational exchange. Similarly, dual phosphorylation on ERK2<sup><xref rid="c39" ref-type="bibr">39</xref></sup> shifts the equilibrium to its active state by about 3kcal/mol while ligand binding to protein kinase A<sup><xref rid="c38" ref-type="bibr">38</xref></sup> induces slow inter-domain motion. This suggests that the solvated kinase catalytic domain samples a diffuse free energy landscape whose topology can be modulated by a number of factors. MSMs present a natural framework to handle these perturbations, and we next focus on the effects of one of them namely protonation of the DFG-Asp539.</p>
<fig id="fig3" position="float" fig-type="figure"><label>Figure 3:</label>
<caption><p><italic>MSMs predict a multistate ensemble whose populations are modulated via DFG protonation. Thermodynamics of the BTK-ASP and BTK-ASH ensembles projected along the two dominant tICs (a) show a stable Src-like state. For standard errors along each coordinate, see Supporting Figure 12. Simple four state cartoon model (b) of the kinase dynamics. Kinetics of several molecular switches as a function of time along a MSM trajectory for BTK-ASP (c). The MSM trajectory was generated using a Monte Carlo algorithm to simulate a trajectory of 800 &#x03BC;s from the Markovian transition matrix. At each step, we randomly selected a simulation structure assigned to that state to report the instantaneous observables. The root mean squared deviation (RMSD) of the A-loop is calculated using the heavy atoms of residue Asp539-Phe559. For A-loop RMSD to the extended state, see Supporting Figure 17. We used the delta carbon of the Glu439 and zeta carbon of Arg468, and the delta carbon of Glu445 and zeta nitrogen of catalytic Lys430 to calculate the distances in the next two panels to quantify C-helix in to out transition. We used Thr410-Val415, and Phe540, Met449, His519, and Leu460 heavy atoms to quantify the P-loop, and R-spine RMSD. The R-spine is only completely formed when the C-helix (orange trace) is rotated inwards. The DFG RMSD is calculated using heavy atoms from Asp539-Gly541. For all RMSD calculations, we used a double helical inactive state as the reference state. The lighter color traces give the instantaneous value for the observable and the dark traces provide moving averages across 10 frames. The color corresponds to the color scheme used in <xref ref-type="fig" rid="fig1">Figure 1</xref> to highlight structural motifs in BTK.</italic></p></caption>
<graphic xlink:href="135913_fig3.tif"/>
</fig>
<p>Based upon pKa calculations<sup><xref rid="c40" ref-type="bibr">40</xref></sup>(Supporting Note 2), and past MD studies on EGFR, Src, and Abl kinases<sup><xref rid="c9" ref-type="bibr">9</xref>,<xref rid="c19" ref-type="bibr">19</xref>,<xref rid="c41" ref-type="bibr">41</xref></sup>, we next selectively protonated DFG-Asp539 (BTK-ASH) to quantify its effects on thermodynamics and kinetics. Our models predict that the DFG<sup>out</sup> state is stabilized by approximately 1 kcal/mol (relative to BTK-ASP&#x2019;s DFG<sup>out</sup>) upon protonating the aspartate (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Compared to BTK-ASP, the increase in DFG<sup>out</sup> population comes from the reduced free energy cost<sup><xref rid="c19" ref-type="bibr">19</xref></sup> of putting a neutral protonated DFG-Asp539 in a hydrophobic environment (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, Supporting Figure 19). Within the BTK-ASH simulation set, we find that the Src-like, active, and DFG<sup>out</sup> states have populations of <inline-formula><alternatives><inline-graphic xlink:href="135913_inline4.gif"/></alternatives></inline-formula>, <inline-formula><alternatives><inline-graphic xlink:href="135913_inline5.gif"/></alternatives></inline-formula>, and <inline-formula><alternatives><inline-graphic xlink:href="135913_inline6.gif"/></alternatives></inline-formula> respectively. Furthermore, we observed that protonation accelerates the DFG flip. To quantify this effect, we calculated the median value for the mean first passage time (MFPT)<sup><xref rid="c42" ref-type="bibr">42</xref>,<xref rid="c43" ref-type="bibr">43</xref></sup> between DFG<sup>in</sup> and DFG<sup>out</sup> states (Supporting Figure 2e and Supporting Figure 8). Starting from the DFG<sup>in</sup> states, the median value for the MFPT to the DFG<sup>out</sup> state reduces from <inline-formula><alternatives><inline-graphic xlink:href="135913_inline7.gif"/></alternatives></inline-formula> in BTK-ASP ensemble to <inline-formula><alternatives><inline-graphic xlink:href="135913_inline8.gif"/></alternatives></inline-formula> in the protonated BTK-ASH ensemble. The reverse value remains relatively similar <inline-formula><alternatives><inline-graphic xlink:href="135913_inline9.gif"/></alternatives></inline-formula>. See SI <xref ref-type="fig" rid="fig2">Figure 2e</xref> and 2f for the full distribution of macro state populations and median DFG MPFTs across several hundred rounds of bootstrapping.</p>
<p>To understand BTK-ASP&#x2019;s kinetics, we sampled multiple long trajectories from the BTK-ASP microstate Markovian transition matrix using a kinetic Monte Carlo algorithm (see Methods). The stochastic algorithm allows us to stitch the shorter trajectories (hundreds of nanoseconds) into a longer &#x201C;mock&#x201D; trajectory that would be otherwise inaccessible by traditional sampling. A representative 800 <italic>&#x03BC;s</italic> trajectory projected along several of the dynamical regions within the kinase domain is illustrated in <xref ref-type="fig" rid="fig3">Figure 3c</xref>. The model predicts that the A-loop is quite flexible, sampling conformations spanning RMSDs on the order of 10s of angstroms (Supporting Figure 17). Such structural heterogeneity within the A-loop has been widely reported in kinase crystal structures<sup><xref rid="c6" ref-type="bibr">6</xref></sup> and MD models of apo<sup><xref rid="c9" ref-type="bibr">9</xref></sup> and ATP<sup><xref rid="c7" ref-type="bibr">7</xref></sup> bound kinases. We find that these transitions are coupled to the outward rotation of the C-helix and flipping of the DFG motif. The outward transition of the C-helix also breaks the regulatory spine (R-spine)<sup><xref rid="c1" ref-type="bibr">1</xref>,<xref rid="c44" ref-type="bibr">44</xref></sup>, which consists of the four conserved residues Met449 (part of the C-helix), Leu460, Phe540 (part of conserved DFG motif) and His519 (part of the conserved HRD motif). Over the course of the simulation, the R-spine samples three distinct macrostates (<xref ref-type="fig" rid="fig3">Figure 3c</xref> purple trace) corresponding to the Src-like, active, and DFG<sup>out</sup> states. In the active state, the R-spine forms a rigid, continuous hydrophobic surface stabilized via multiple Van der Walls interactions. These interactions are broken in the inactive states (Supporting Table 1) where the Met449 moves out of the core of the protein and Phe540 adopts a range of configurations (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<p>Interestingly, our model predicts that the kinase deactivation to a Src-like state (A-loop folded, DFG<sup>in</sup>, &#x0026; C-helix<sup>out</sup>, <xref ref-type="fig" rid="fig3">Figure 3c</xref> between the 350-450<italic>&#x03BC;s</italic> mark) quenches motions in the dynamic glycine-rich phosphate positioning loop (P-loop, <xref ref-type="fig" rid="fig3">Figure 3c</xref> green trace). The P-loop samples open and closed configurations in the active and DFG<sup>out</sup> states. However, the P-loop closes when the A-loop folds. Our model indicates this rigidity is due to both the formation of a new backbone hydrogen bond (Supporting Figure 14) between Lys433 and Phe413 and favorable p-stacking (Supporting Figure 14) between Leu542 and Phe413.</p>
</sec>
<sec id="s1c">
<title>Deactivation proceeds through an intermediate state</title>
<p>We now turn to the structural changes involved in the two dominant apo BTK transitions, namely active (C-helix<sup>in</sup>/DFG<sup>in</sup>) to Src-like (A-loop folded/C-helix<sup>out</sup>/DFG<sup>in</sup>) and DFG<sup>out</sup> to DFG<sup>in</sup>. Like most kinases<sup><xref rid="c44" ref-type="bibr">44</xref>&#x2013;<xref rid="c46" ref-type="bibr">46</xref></sup>, BTK&#x2019;s active state features the C-helix rotated towards the core of the protein, enabling the formation of a critical<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c47" ref-type="bibr">47</xref></sup> salt bridge between the Glu445 and Lys430 (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). The A-loop is extended and transiently forms a beta-sheet.</p>
<fig id="fig4" position="float" fig-type="figure"><label>Figure 4:</label>
<caption><p><italic>BTK&#x2019;s deactivation proceeds via an intermediate state. Starting from the active state (a), the C-helix swings out to form an intermediate (b) characterized by a disordered A-loop and a stable Arg468-Glu439 salt bridge. The activation loop then folds into a Src-like double helical inactive state (c). The double helical state is stabilized by a secondary salt bridge between the catalytic Glu445 and Arg544. The P-loop has been omitted in all three panels for the sake of clarity. The heat map (d) shows the projection of the centroids of these states unto our free energy landscape. Panel (d) has been reproduced from <xref ref-type="fig" rid="fig3">Figure 3</xref> for clarity.</italic></p></caption>
<graphic xlink:href="135913_fig4.tif"/>
</fig>
<p>Deactivation to a Src-like state exposes an allosteric binding pocket. In both the BTK-ASP and BTK-ASH ensembles, deactivation to a Src-like state follows a two-step<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c9" ref-type="bibr">9</xref>,<xref rid="c19" ref-type="bibr">19</xref>,<xref rid="c24" ref-type="bibr">24</xref>,<xref rid="c25" ref-type="bibr">25</xref></sup> process. In the first step, the C-helix rotates out of the core of the protein (Supporting Figure 13) to a metastable intermediate conformation (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). In several of our trajectories the C-helix rotation was preceded by a backbone shift at the N-terminus region of the A-loop. This intermediate is stabilized by a salt bridge between Arg468 and Glu439. The A-loop is still relatively unstructured but transiently samples partially helical states (Supporting Figure 5). The outward rotation of the C-helix to the catalytically inactive intermediate state opens an allosteric pocket (Supporting Figure 4)<sup><xref rid="c7" ref-type="bibr">7</xref></sup>, which can potentially be used to design selective BTK inhibitors. Supporting Movie 1 contains an example of one of our BTK-ASP trajectories that spontaneously goes from the active to the intermediate.</p>
<p>Starting from the intermediate state, the A-loop folds into a double helix. This state forms a deep free energy basin in our MSM (<xref ref-type="fig" rid="fig4">Figures 4c-d</xref>). The inactive state is stabilized by the presence of two complementary salt bridges (Glu439-Arg468 and Glu445-Arg544<sup><xref rid="c5" ref-type="bibr">5</xref>,<xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c8" ref-type="bibr">8</xref></sup>, <xref ref-type="fig" rid="fig4">Figure 4c</xref>). Within several milliseconds of aggregate sampling, we do not observe a deactivation event where the A-loop folds prior to the outward rotation of the C-helix, suggesting that this pathway is thermodynamically inaccessible.</p>
</sec>
<sec id="s1d">
<title>DFG flip occurs via the C-lobe</title>
<p>We observed several partial and complete DFG transitions for the BTK-ASP and BTK-ASH ensembles in trajectories that lasted hundreds of nanoseconds to a few microseconds (Supporting Movies 2-4). For both ensembles, our MSMs inferred the equilibrium populations and kinetics using all of the trajectories, regardless of whether they contained a crossover event (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig5">Figure 5d</xref>).</p>
<fig id="fig5" position="float" fig-type="figure"><label>Figure 5:</label>
<caption><p><italic>BTK DFG flips via the C-lobe, and proceeds after the formation of a helical intermediate state (a). Snapshots (b) going from red to white to blue, from the DFG</italic><sup><italic>out</italic></sup> <italic>to DFG</italic><sup><italic>in</italic></sup> <italic>trajectory showing the transient outward rotation of Met449 and Phe517 for the DFG flip. The DFG</italic><sup><italic>out</italic></sup> <italic>to DFG</italic><sup><italic>in</italic></sup> <italic>cross-over (c, panel 1) is preceded by the folding of residues Ser543-Leu547 (c, panel 2) and transient outward rotation of both Met449 and Phe517 (c, panel 3). Projection of the 3 selected frames from (b) onto the top two tICs (d) gives us the approximate free energies of the DFG</italic><sup><italic>out</italic></sup>, <italic>intermediate and DFG</italic><sup><italic>in</italic></sup> <italic>states.</italic></p></caption>
<graphic xlink:href="135913_fig5.tif"/>
</fig>
<p><xref ref-type="fig" rid="fig5">Figure 5</xref> shows the details of one of the transition trajectories from the BTK-ASH ensemble starting from the 3OCT crystal structure with an unfolded A-loop and DFG<sup>out</sup> state (Supporting Movie 2). Within the trajectory, the A-loop first folds into the ATP binding site, forming a helical intermediate (<xref ref-type="fig" rid="fig5">Figure 5c</xref>, Supporting Figure 18). In this intermediate, residues Leu542 to Leu547 form a helical turn that folds into the kinase&#x2019;s core though the rest of the A-loop remains mobile. This intermediate has been previously reported<sup><xref rid="c9" ref-type="bibr">9</xref>,<xref rid="c19" ref-type="bibr">19</xref></sup> for the EGFR kinase. Furthermore, Kuglstatter et al<sup><xref rid="c21" ref-type="bibr">21</xref></sup> reported a DFG<sup>in</sup> crystal structure for BTK where the the A-loop folds into the ATP binding site, demonstrating its [meta]stability. Within our simulation, the BTK-ASH molecule samples this intermediate until the DFG-Phe rotates towards the core of the protein (<xref ref-type="fig" rid="fig5">Figure 5b</xref>, white) coming on to the same side as the DFG-Asp. In the last step, the DFG-Asp moves into the ATP binding site, completing the crossover transition.</p>
<p>While no unbiased MD simulation results exist for the DFG flip for either BTK-ASP or BTK-ASH molecule, the pathway presented here diverges from EGFR kinase&#x2019;s DFG-flip pathway<sup><xref rid="c9" ref-type="bibr">9</xref></sup> in two aspects. In the previous simulations, the DFG-Phe residue flips by moving across the N-lobe of the kinase. Within our model, the phenylalanine residue exclusively moves via the C-lobe of the kinase while the aspartate moves via the N-lobe (Supporting Figure 15). This sequence is conserved in both the full and partial trajectories (Supporting Movies 2-4) that transition from the DFG<sup>in</sup> state to the DFG<sup>out</sup> state and vice versa. To our knowledge, this mechanism has never been proposed, though that is likely due to the computational difficulties of simulating the DFG flip transition. It is worth noting that our distributed computing approach<sup><xref rid="c26" ref-type="bibr">26</xref></sup> allowed us to sample the DFG flip in an unbiased fashion using commodity GPUs, and our MSM was able to capture the DFG transition as the slowest mode within our tICA model. Secondly, while we do observe the presence of a helical intermediate state in several of the transitions, we also observed a DFG<sup>out</sup> to DFG<sup>in</sup> transition for the BTK-ASP molecule in which the A-loop remains unstructured (Supporting Movie 3). The litany of flipping pathways follows from the inherent stochasticity of molecular conformational change and emphasizes the need for extensive sampling and robust statistical modeling.</p>
<p>Three residues sterically and chemically hinder the DFG transition. The conserved catalytic Lys430 hydrogen bonds with the DFG-Asp539 while the conserved Met449 sterically prevents rotation of the DFG-Asp539 towards the ATP binding site. On the other side, Phe517 (<xref ref-type="fig" rid="fig5">Figure 5b</xref>-c) hinders the rotation of the DFG-Phe540 towards the protein core. Previous MD studies<sup><xref rid="c9" ref-type="bibr">9</xref>,<xref rid="c19" ref-type="bibr">19</xref></sup> of the DFG flip observed spontaneous DFG transitions upon <italic>in-silico</italic> mutations of Met449, or its equivalent residue, and protonation of the DFG-Asp. As previously proposed, our data supports that protonation of the DFG-Asp can increase the likelihood of a spontaneous DFG flip. Our comparison of BTK-ASH to BTK-ASP showed that the DFG<sup>out</sup> state is stabilized by 1kcal/mol upon DFG-Asp539 protonation. However, the combined effect of both DFG protonation and Met449 mutation remains to be observed. Lastly, while our simulations showed that the collapse of the folded A-loop into the kinase core predominantly precedes the DFG flip, it is not necessarily required, highlighting the ensemble nature of the pathway.</p>
<p>To summarize, the present results offer a detailed atomistic description of the thermodynamics and kinetics of the protonated and deprotonated forms of the apo BTK catalytic domain. Our model predicts that the apo kinase domain samples a range of conformational states that are yet to be crystallized but for which equivalent structures from other kinase domains exist. We complete structural modeling of a DFG<sup>out</sup> binding pocket for BTK, which could potentially be used to design a new class of BTK inhibitors. Furthermore, our model indicates that a structurally diverse intermediate state connects the active, Src-like, and DFG<sup>out</sup> states. For the first time, our results provide estimates for the equilibrium populations of all three dominant kinase states within a single model.</p>
<p>While we have chosen to separately analyze the BTK-ASP and BTK-ASH ensembles, the BTK ensemble in solution is a combination of both modulated by the DFG-Aspartate&#x2019;s pKa in each microstate. Modeling this ensemble coupling would ideally require the use of constant pH simulations but can also be done post-hoc by analytical mixing of the parameterized transition matrices. This would entail running short constant pH(or QM/MM<sup><xref rid="c48" ref-type="bibr">48</xref>,<xref rid="c49" ref-type="bibr">49</xref></sup>) simulations to link the microstates, and is the subject of future research. Perhaps more interestingly, our BTK-ASP and BTK-ASH MSMs use a single set of state definitions, allowing us to explicitly compare relative free energies of differing kinase states. This can be extended to understanding the thermodynamic and kinetic effects of small molecule binding, mutations, regulatory domains, and post-transitional modifications. Given enough computational resources, it is theoretically possible to model all 602 known BTK mutations in the X-linked agammaglobulinemia database<sup><xref rid="c16" ref-type="bibr">16</xref></sup>. Such detailed atomistic characterization could be used to design the next generation of personalized and specific kinase inhibitors while increasing our understanding of the fundamental interplay between sequence and function.</p>
</sec>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2a">
<title>Simulation setup</title>
<p>The Supporting information contains a more detailed methods section. Briefly, we downloaded 23 publically available BTK pdbs from the protein databank<sup><xref rid="c50" ref-type="bibr">50</xref></sup>, and used Modeller<sup><xref rid="c51" ref-type="bibr">51</xref></sup> with default parameters to mutate out all the sequences to the human sequence for both BTK-ASP and BTK-ASH ensembles. We only kept the protein coordinates and removed all ligands (21 of the 23 structures had a co-crystal ligand). In cases, where the P-loop, C-helix or A-loop was un-resolved, we modeled them in as an extended chain. Amber tools suite<sup><xref rid="c52" ref-type="bibr">52</xref>&#x2013;<xref rid="c54" ref-type="bibr">54</xref></sup> was used to solvate the protein structures in a water box and add counter ions. The Amber99sb-ildn<sup><xref rid="c55" ref-type="bibr">55</xref></sup> force field was used to model protein dynamics in conjunction with the TIP3P<sup><xref rid="c56" ref-type="bibr">56</xref></sup> water model. The structures were minimized in two steps using Amber and then loaded into OpenMM<sup><xref rid="c57" ref-type="bibr">57</xref></sup> for NPT production runs on Folding&#x0040;home<sup><xref rid="c26" ref-type="bibr">26</xref></sup>. Overall we generated 1.7ms of aggregate data for both ensembles.</p>
</sec>
<sec id="s2b">
<title>Markov state model</title>
<p>Building a MSM requires identification of metastable kinetically similar states. This splitting of the phase space is followed by counting the transitions between those states as observed in our trajectories at a Markovian (memory free) lag time. This transition model can be summarized using the following equation:
<disp-formula id="ueqn1">
<alternatives>
<graphic xlink:href="135913_ueqn1.gif"/>
</alternatives>
</disp-formula>
where <italic>p</italic>(<italic>t</italic>) is the probability distribution at time &#x201C;t&#x201D; while <italic>p</italic>(<italic>t</italic> &#x002B; <italic>&#x03C4;</italic>) is the probability distribution after a Markovian lagtime <italic>&#x03C4;</italic>. Spectral decomposition of the MSM transition matrix was used to estimate the equilibrium populations and dynamical processes connecting those Markov states. The relaxation timescales for these dynamical processes can be obtained by using the following transformation on the associated eigenvalue <italic>&#x03BC;</italic>
<disp-formula id="ueqn2">
<alternatives>
<graphic xlink:href="135913_ueqn2.gif"/>
</alternatives>
</disp-formula>
After sampling the MD trajectories using Folding&#x0040;home, a total of 2,140 trajectories were vectorized using the protein dihedrals and selective closest heavy atom distances. This feature selection led to each frame being represented as a feature vector of length 5,532. We normalized the data and reduced its dimensionality using time structure independent component analysis (tICA)<sup><xref rid="c32" ref-type="bibr">32</xref>,<xref rid="c35" ref-type="bibr">35</xref></sup>. tICA seeks to find a set of linear combinations of features that de-correlate the slowest (at a certain lag time) while minimizing their correlation. This is done by solving the following generalized eigenvalue problem:
<disp-formula id="ueqn3">
<alternatives>
<graphic xlink:href="135913_ueqn3.gif"/>
</alternatives>
</disp-formula>
where <italic>&#x03A3;</italic> is the covariance matrix
<disp-formula id="ueqn4">
<alternatives>
<graphic xlink:href="135913_ueqn4.gif"/>
</alternatives>
</disp-formula>
and <italic>C</italic>(&#x03C4;) is the time lagged correlation matrix whose ij element is defined as
<disp-formula id="ueqn5">
<alternatives>
<graphic xlink:href="135913_ueqn5.gif"/>
</alternatives>
</disp-formula>
Here, <italic>&#x03C4;</italic> is the tICA lagtime and can be different from Markovian lagtime. The tICA-transformed dataset was clustered using the K-means algorithm. We then used the cluster labeled dataset to build a MSM. For all projections, the deprotonated (BTK<sub>ASP</sub>) ensemble&#x2019;s highest populated state was assigned an absolute free energy of 0 kcal/mol and all other free energies were reported relative to that state. Based upon previous work<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c58" ref-type="bibr">58</xref></sup> and the convergence of the implied timescales plot (Supporting Figure 1) for 50-500 state models, we chose a Markovian lag time of 80 ns. For all the other hyper-parameters, including the tICA lagtime, choice of kinetic mapping, number of tICA components, and number of cluster states, within the model, we turned to cross validation<sup><xref rid="c36" ref-type="bibr">36</xref>,<xref rid="c37" ref-type="bibr">37</xref></sup>. The parameters for the best model are given below:
<table-wrap id="utbl1" orientation="portrait" position="float">
<graphic xlink:href="135913_utbl1.tif"/>
</table-wrap>
After we determined the optimal model given the current amount of sampling, we retrained the model on the entire set of trajectories. For the reported tICA model, we used a sparse variant of tICA<sup><xref rid="c34" ref-type="bibr">34</xref></sup> for increased interpretability (Supporting Figure 6-7). The Markov transition matrix was fit via maximum likelihood estimation (MLE) with reversibility and ergodicity constraints. To obtain error bars for the equilibrium populations, 200 rounds of bootstrapping were performed over the original set of trajectories. The models were primarily analyzed using techniques laid out in previous papers<sup><xref rid="c35" ref-type="bibr">35</xref>,<xref rid="c59" ref-type="bibr">59</xref></sup>. To further query the model, we sampled an 800 &#x03BC;s long kinetic Monte Carlo trajectory (10,000 frames at a lagtime of 80 ns) from the Markovian transition matrix.</p>
<p>The trajectories were featurized and analyzed using the MDTraj<sup><xref rid="c60" ref-type="bibr">60</xref></sup> package while tICA dimensionality reduction and Markov modeling were performed using MSMBuilder<sup><xref rid="c61" ref-type="bibr">61</xref></sup>. Most of the analysis was performed within the IPython/Jupyter scientific environment<sup><xref rid="c62" ref-type="bibr">62</xref></sup> with extensive use of the matplotlib<sup><xref rid="c63" ref-type="bibr">63</xref></sup>, and scikit-learn libraries<sup><xref rid="c64" ref-type="bibr">64</xref></sup>. All protein images were generated using visual molecular dynamics (VMD)<sup><xref rid="c65" ref-type="bibr">65</xref></sup>, all protein surfaces were rendered using SURF<sup><xref rid="c66" ref-type="bibr">66</xref></sup>,and secondary structure was assigned using STRIDE<sup><xref rid="c67" ref-type="bibr">67</xref></sup> as implemented in VMD.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>M.M.S acknowledges support from NSF-MCB-0954714. All authors acknowledge monetary support from the Pfizer Science &#x0026; Technology budget. M.M.S would also like to thank Carlos Xavier Hernandez, Brooke Husic, Evan Feinberg, Ariana Peck, and other members of the Pande group for critical discussions and reading of the manuscript. The authors would like to thank Yatish Jain assisting with order parameter scripting and Mark Bunnage and John Mathias for their constant encouragement and support.</p>
</ack>
<ref-list>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Taylor</surname>, <given-names>S. S.</given-names></string-name> &#x0026; <string-name><surname>Kornev</surname>, <given-names>A. P.</given-names></string-name> <article-title>Protein Kinases: Evolution of Dynamic Regulatory Proteins</article-title>. <source>Trends Biochem. Sci</source>. <volume>36</volume>, <fpage>65</fpage>&#x2013;<lpage>77</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Parsons</surname>, <given-names>S. J.</given-names></string-name> &#x0026; <string-name><surname>Parsons</surname>, <given-names>J. T.</given-names></string-name> <article-title>Src family kinases, key regulators of signal transduction</article-title>. <source>Oncogene</source> <volume>23</volume>, <fpage>7906</fpage>&#x2013;<lpage>9</lpage> (<year>2004</year>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Endicott</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Noble</surname>, <given-names>M. E. M.</given-names></string-name> &#x0026; <string-name><surname>Johnson</surname>, <given-names>L. N.</given-names></string-name> <article-title>The structural basis for control of eukaryotic protein kinases</article-title>. <source>Annu. Rev. Biochem</source>. <volume>81</volume>, <fpage>587</fpage>&#x2013;<lpage>613</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Hanks</surname>, <given-names>S. K.</given-names></string-name> &#x0026; <string-name><surname>Hunter</surname>, <given-names>T.</given-names></string-name> <article-title>The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</article-title>. <source>FASEB J</source>. <volume>9</volume>, <fpage>576</fpage>&#x2013;<lpage>96</lpage> (<year>1995</year>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Levinson</surname>, <given-names>N. M.</given-names></string-name> <etal>et al.</etal> <article-title>A Src-like inactive conformation in the abl tyrosine kinase domain</article-title>. <source>PLoS Biol</source>. <volume>4</volume>, <fpage>e144</fpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Huse</surname>, <given-names>M.</given-names></string-name> &#x0026; <string-name><surname>Kuriyan</surname>, <given-names>J.</given-names></string-name> <source>The Conformational Plasticity of Protein Kinases</source>. <volume>109</volume>, <fpage>275</fpage>&#x2013;<lpage>282</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Shukla</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Meng</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Roux</surname>, <given-names>B.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Activation pathway of Src kinase reveals intermediate states as targets for drug design</article-title>. <source>Nat. Commun</source>. <volume>5</volume>, <fpage>3397</fpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Foda</surname>, <given-names>Z. H.</given-names></string-name>, <string-name><surname>Shan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>E. T.</given-names></string-name>, <string-name><surname>Shaw</surname>, <given-names>D. E.</given-names></string-name> &#x0026; <string-name><surname>Seeliger</surname>, <given-names>M. A.</given-names></string-name> <article-title>A dynamically coupled allosteric network underlies binding cooperativity in Src kinase</article-title>. <source>Nat. Commun</source>. <volume>6</volume>, <fpage>5939</fpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Arkhipov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>E. T.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>A. C.</given-names></string-name> &#x0026; <string-name><surname>Shaw</surname>, <given-names>D. E.</given-names></string-name> <article-title>Transitions to catalytically inactive conformations in EGFR kinase</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>110</volume>, <fpage>7270</fpage>&#x2013;<lpage>5</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Greuber</surname>, <given-names>E. K.</given-names></string-name>, <string-name><surname>Smith-Pearson</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name> &#x0026; <string-name><surname>Pendergast</surname>, <given-names>A. M.</given-names></string-name> <article-title>Role of ABL family kinases in cancer: from leukaemia to solid tumours</article-title>. <source>Nat. Rev. Cancer</source> <volume>13</volume>, <fpage>559</fpage>&#x2013;<lpage>71</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Jope</surname>, <given-names>R. S.</given-names></string-name> &#x0026; <string-name><surname>Johnson</surname>, <given-names>G. V. W.</given-names></string-name> <article-title>The glamour and gloom of glycogen synthase kinase-3</article-title>. <source>Trends Biochem. Sci</source>. <volume>29</volume>, <fpage>95</fpage>&#x2013;<lpage>102</lpage> (<year>2004</year>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name> <etal>et al.</etal> <article-title>Autoinhibition of Bruton&#x2019;s tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate</article-title>. <source>Elife</source> <volume>4</volume>, <fpage>e06074</fpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Mohamed</surname>, <given-names>A. J.</given-names></string-name> <etal>et al.</etal> <article-title>Bruton&#x2019;s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain</article-title>. <source>Immunol. Rev</source>. <volume>228</volume>, <fpage>58</fpage>&#x2013;<lpage>73</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Marcotte</surname>, <given-names>D. J.</given-names></string-name> <etal>et al.</etal> <article-title>Structures of human Bruton&#x2019;s tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases</article-title>. <source>Protein Sci</source>. <volume>19</volume>, <fpage>429</fpage>&#x2013;<lpage>39</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Dinh</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title>Activation mechanism and steady state kinetics of Bruton&#x2019;s tyrosine kinase</article-title>. <source>J. Biol. Chem</source>. <volume>282</volume>, <fpage>8768</fpage>&#x2013;<lpage>76</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>V&#x00E4;liaho</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>C. I. E.</given-names></string-name> &#x0026; <string-name><surname>Vihinen</surname>, <given-names>M.</given-names></string-name> <article-title>BTKbase: the mutation database for X-linked agammaglobulinemia</article-title>. <source>Hum. Mutat</source>. <volume>27</volume>, <fpage>1209</fpage>&#x2013;<lpage>17</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Hendriks</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Yuvaraj</surname>, <given-names>S.</given-names></string-name> &#x0026; <string-name><surname>Kil</surname>, <given-names>L. P.</given-names></string-name> <article-title>Targeting Bruton&#x2019;s tyrosine kinase in B cell malignancies</article-title>. <source>Nat. Rev. Cancer</source> <volume>14</volume>, <fpage>219</fpage>&#x2013;<lpage>232</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>M&#x00F6;bitz</surname>, <given-names>H.</given-names></string-name> <article-title>The ABC of protein kinase conformations</article-title>. <source>Biochim. Biophys. Acta - Proteins Proteomics</source> <volume>1854</volume>, <fpage>1555</fpage>&#x2013;<lpage>1566</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title>A conserved protonation-dependent switch controls drug binding in the Abl kinase</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>106</volume>, <fpage>139</fpage>&#x2013;<lpage>44</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Sicheri</surname>, <given-names>F.</given-names></string-name> &#x0026; <string-name><surname>Kuriyan</surname>, <given-names>J.</given-names></string-name> <article-title>Structures of Src-family tyrosine kinases</article-title>. <source>Curr. Opin. Struct. Biol</source>. <volume>7</volume>, <fpage>777</fpage>&#x2013;<lpage>85</lpage> (<year>1997</year>).</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Kuglstatter</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>Insights into the conformational flexibility of Bruton&#x2019;s tyrosine kinase from multiple ligand complex structures</article-title>. <source>Protein Sci</source>. <volume>20</volume>, <fpage>428</fpage>&#x2013;<lpage>436</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Doshi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lei</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Eck</surname>, <given-names>M. J.</given-names></string-name> &#x0026; <string-name><surname>Harrison</surname>, <given-names>S. C.</given-names></string-name> <article-title>Crystal structures of c-Src reveal features of its autoinhibitory mechanism</article-title>. <source>Mol. Cell</source> <volume>3</volume>, <fpage>629</fpage>&#x2013;<lpage>38</lpage> (<year>1999</year>).</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Ozkirimli</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Yadav</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>W.</given-names></string-name> &#x0026; <string-name><surname>Post</surname>, <given-names>C.</given-names></string-name> <article-title>An electrostatic network and long-range regulation of Src kinases</article-title>. <source>Protein Sci</source>. <volume>295</volume>, <fpage>1871</fpage>&#x2013;<lpage>1880</lpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Gan</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>S.</given-names></string-name> &#x0026; <string-name><surname>Roux</surname>, <given-names>B.</given-names></string-name> <article-title>Atomistic view of the conformational activation of Src kinase using the string method with swarms-of-trajectories</article-title>. <source>Biophys. J</source>. <volume>97</volume>, <fpage>L8</fpage>&#x2013;<lpage>L10</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Banavali</surname>, <given-names>N. K.</given-names></string-name> &#x0026; <string-name><surname>Roux</surname>, <given-names>B.</given-names></string-name> <article-title>Mapping the conformational transition in Src activation by cumulating the information from multiple molecular dynamics trajectories</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>106</volume>, <fpage>3776</fpage>&#x2013;<lpage>3781</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="other"><string-name><surname>Shirts</surname>, <given-names>M.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Screen Savers of the World Unite! <italic>Science</italic></article-title> <volume>290</volume>, <fpage>1903</fpage>&#x2013;<lpage>1904</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Chopra</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal> <article-title>Dynamic Allostery Mediated by a Conserved Tryptophan in the Tec Family Kinases</article-title>. <source>PLoS Comput. Biol</source>. <volume>12</volume>, <fpage>e1004826</fpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name>, <string-name><surname>Beauchamp</surname>, <given-names>K.</given-names></string-name> &#x0026; <string-name><surname>Bowman</surname>, <given-names>G. R.</given-names></string-name> <article-title>Everything you wanted to know about Markov State Models but were afraid to ask</article-title>. <source>Methods</source> <volume>52</volume>, <fpage>99</fpage>&#x2013;<lpage>105</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Bowman</surname>, <given-names>G. R.</given-names></string-name>, <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> &#x0026; <string-name><surname>No&#x00E9;</surname>, <given-names>F.</given-names></string-name> <source>An Introduction to Markov State Models and Their Application to Long Timescale Molecular Simulation</source>. <volume>797</volume>, (<year>2014</year>).</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Nagar</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title>Structural basis for the autoinhibition of c-Abl tyrosine kinase</article-title>. <source>Cell</source> <volume>112</volume>, <fpage>859</fpage>&#x2013;<lpage>71</lpage> (<year>2003</year>).</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Pendergast</surname>, <given-names>A. M.</given-names></string-name> <article-title>The Abl family kinases: Mechanisms of regulation and signaling</article-title>. <source>Advances in Cancer Research</source> <volume>85</volume>, <fpage>51</fpage>&#x2013;<lpage>100</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Schwantes</surname>, <given-names>C. R.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Improvements in Markov State Model Construction Reveal Many Non-Native Interactions in the Folding of NTL9</article-title>. <source>J. Chem. Theory Comput</source>. <volume>9</volume>, <fpage>2000</fpage>&#x2013;<lpage>2009</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>No&#x00E9;</surname>, <given-names>F.</given-names></string-name> &#x0026; <string-name><surname>Clementi</surname>, <given-names>C.</given-names></string-name> <article-title>Kinetic distance and kinetic maps from molecular dynamics simulation</article-title>. <source>J. Chem. Theory Comput</source>. <volume>11</volume>, <fpage>5002</fpage>&#x2013;<lpage>5011</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="other"><string-name><surname>McGibbon</surname>, <given-names>R. T.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <source>Identification of simple reaction coordinates from complex dynamics</source>. <fpage>1</fpage>&#x2013;<lpage>16</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>P&#x00E9;rez-Hern&#x00E1;ndez</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal> <article-title>Identification of slow molecular order parameters for Markov model construction</article-title>. <source>J. Chem. Phys</source>. <volume>139</volume>, <fpage>15102</fpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>McGibbon</surname>, <given-names>R. T.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Variational cross-validation of slow dynamical modes in molecular kinetics</article-title>. <source>J. Chem. phyics</source> <volume>142</volume>, (<year>2015</year>).</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>N&#x00FC;ske</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Keller</surname>, <given-names>B. G.</given-names></string-name>, <string-name><surname>P&#x00E9;rez-Hern&#x00E1;ndez</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mey</surname>, <given-names>A. S. J. S.</given-names></string-name> &#x0026; <string-name><surname>No&#x00E9;</surname>, <given-names>F.</given-names></string-name> <article-title>Variational Approach to Molecular Kinetics</article-title>. <source>J. Chem. Theory Comput</source>. <volume>10</volume>, <fpage>1739</fpage>&#x2013;<lpage>52</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Xiao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liddle</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Pardi</surname>, <given-names>A.</given-names></string-name> &#x0026; <string-name><surname>Ahn</surname>, <given-names>N. G.</given-names></string-name> <article-title>Dynamics of protein kinases: Insights from nuclear magnetic resonance</article-title>. <source>Acc. Chem. Res</source>. <volume>48</volume>, <fpage>1106</fpage>&#x2013;<lpage>1114</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Xiao</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title>Phosphorylation releases constraints to domain motion in ERK2</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>111</volume>, <fpage>2506</fpage>&#x2013;<lpage>11</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Gordon</surname>, <given-names>J. C.</given-names></string-name> <etal>et al.</etal> <article-title>H&#x002B;&#x002B;: a server for estimating pKas and adding missing hydrogens to macromolecules</article-title>. <source>Nucleic Acids Res</source>. <volume>33</volume>, <fpage>W368</fpage>&#x2013;<lpage>71</lpage> (<year>2005</year>).</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Meng</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y. L.</given-names></string-name> &#x0026; <string-name><surname>Roux</surname>, <given-names>B.</given-names></string-name> <article-title>Computational study of the &#x2018;DFG-Flip&#x2019; conformational transition in c-Abl and c-Src tyrosine kinases</article-title>. <source>J. Phys. Chem. B</source> <volume>119</volume>, <fpage>1443</fpage>&#x2013;<lpage>1456</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Hinrichs</surname>, <given-names>N. S.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Calculation of the distribution of eigenvalues and eigenvectors in Markovian state models for molecular dynamics</article-title>. <source>J. Chem. Phys</source>. <volume>126</volume>, <fpage>244101</fpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>No&#x00E9;</surname>, <given-names>F.</given-names></string-name> &#x0026; <string-name><surname>Fischer</surname>, <given-names>S.</given-names></string-name> <article-title>Transition networks for modeling the kinetics of conformational change in macromolecules</article-title>. <source>Curr. Opin. Struct. Biol</source>. <volume>18</volume>, <fpage>154</fpage>&#x2013;<lpage>62</lpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Kornev</surname>, <given-names>A. P.</given-names></string-name>, <string-name><surname>Haste</surname>, <given-names>N. M.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>S. S.</given-names></string-name> &#x0026; <string-name><surname>Eyck</surname>, <given-names>L. F. T.</given-names></string-name> <article-title>Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>103</volume>, <fpage>17783</fpage>&#x2013;<lpage>8</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Cowan-Jacob</surname>, <given-names>S. W.</given-names></string-name> <etal>et al.</etal> <article-title>The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation</article-title>. <source>Structure</source> <volume>13</volume>, <fpage>861</fpage>&#x2013;<lpage>71</lpage> (<year>2005</year>).</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>, <given-names>L. N.</given-names></string-name>, <string-name><surname>Noble</surname>, <given-names>M. E. M.</given-names></string-name> &#x0026; <string-name><surname>Owen</surname>, <given-names>D. J.</given-names></string-name> <article-title>Active and inactive protein kinases: Structural basis for regulation</article-title>. <source>Cell</source> <volume>85</volume>, <fpage>149</fpage>&#x2013;<lpage>158</lpage> (<year>1996</year>).</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>S.</given-names></string-name> &#x0026; <string-name><surname>Roux</surname>, <given-names>B.</given-names></string-name> <article-title>Src kinase conformational activation: thermodynamics, pathways, and mechanisms</article-title>. <source>PLoS Comput. Biol</source>. <volume>4</volume>, <fpage>e1000047</fpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Van Der Kamp</surname>, <given-names>M. W.</given-names></string-name> &#x0026; <string-name><surname>Mulholland</surname>, <given-names>A. J.</given-names></string-name> <article-title>Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology</article-title>. <source>Biochemistry</source> <volume>52</volume>, <fpage>2708</fpage>&#x2013;<lpage>2728</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="book"><string-name><surname>Warshel</surname>, <given-names>A.</given-names></string-name> &#x0026; <string-name><surname>Florian</surname>, <given-names>J.</given-names></string-name> <source>in Encyclopedia of Computational Chemistry</source> (<publisher-name>John Wiley &#x0026; Sons, Ltd</publisher-name>, <year>2002</year>). doi:<pub-id pub-id-type="doi">10.1002/0470845015.cu0002</pub-id></mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Berman</surname>, <given-names>H. M.</given-names></string-name> <article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res</source>. <volume>28</volume>, <fpage>235</fpage>&#x2013;<lpage>242</lpage> (<year>2000</year>).</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Eswar</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal> <article-title>Comparative protein structure modeling using MODELLER</article-title>. <source>Curr. Protoc. Protein Sci</source>. Chapter <volume>2</volume>, <comment>Unit 2.9</comment> (<year>2007</year>).</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Salomon-Ferrer</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Case</surname>, <given-names>D. A.</given-names></string-name> &#x0026; <string-name><surname>Walker</surname>, <given-names>R. C.</given-names></string-name> <article-title>An overview of the Amber biomolecular simulation package</article-title>. <source>Wiley Interdiscip. Rev. Comput. Mol. Sci</source>. <volume>3</volume>, <fpage>198</fpage>&#x2013;<lpage>210</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>G&#x00F6;tz</surname>, <given-names>A. W.</given-names></string-name> <etal>et al.</etal> <article-title>Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born</article-title>. <source>J. Chem. Theory Comput</source>. <volume>8</volume>, <fpage>1542</fpage>&#x2013;<lpage>1555</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Salomon-Ferrer</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>G&#x00F6;tz</surname>, <given-names>A. W.</given-names></string-name>, <string-name><surname>Poole</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Le Grand</surname>, <given-names>S.</given-names></string-name> &#x0026; <string-name><surname>Walker</surname>, <given-names>R. C.</given-names></string-name> <article-title>Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald</article-title>. <source>J. Chem. Theory Comput</source>. <volume>9</volume>, <fpage>3878</fpage>&#x2013;<lpage>3888</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Lindorff-Larsen</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title>Improved side-chain torsion potentials for the Amber ff99SB protein force field</article-title>. <source>Proteins</source> <volume>78</volume>, <fpage>1950</fpage>&#x2013;<lpage>8</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Jorgensen</surname>, <given-names>W. L.</given-names></string-name>, <string-name><surname>Chandrasekhar</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Madura</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Impey</surname>, <given-names>R. W.</given-names></string-name> &#x0026; <string-name><surname>Klein</surname>, <given-names>M. L.</given-names></string-name> <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source>J. Chem. Phys</source>. <volume>79</volume>, <fpage>926</fpage> (<year>1983</year>).</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Eastman</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title>OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation</article-title>. <source>J. Chem. Theory Comput</source>. <volume>9</volume>, <fpage>461</fpage>&#x2013;<lpage>469</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Kohlhoff</surname>, <given-names>K. J.</given-names></string-name> <etal>et al.</etal> <article-title>Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways</article-title>. <source>Nat. Chem</source>. <volume>6</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Sultan</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Kiss</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Shukla</surname>, <given-names>D.</given-names></string-name> &#x0026; <string-name><surname>Pande</surname>, <given-names>V. S.</given-names></string-name> <article-title>Automatic Selection of Order Parameters in the Analysis of Large Scale Molecular Dynamics Simulations</article-title>. <source>J. Chem. Theory Comput</source>. <volume>10</volume>, <fpage>5217</fpage>&#x2013;<lpage>5223</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="other"><string-name><surname>Mcgibbon</surname>, <given-names>R. T.</given-names></string-name> <etal>et al.</etal> <article-title>MDTraj: a modern, open library for the analysis of molecular dynamics trajectories</article-title>. <source>bioRxiv</source> <fpage>9</fpage>&#x2013;<lpage>10</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Beauchamp</surname>, <given-names>K. A.</given-names></string-name> <etal>et al.</etal> <article-title>MSMBuilder2: modeling conformational dynamics on the picosecond to millisecond scale</article-title>. <source>J. Chem. Theory Comput</source>. <volume>7</volume>, <fpage>3412</fpage>&#x2013;<lpage>3419</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>P&#x00E9;rez</surname>, <given-names>F.</given-names></string-name> &#x0026; <string-name><surname>Granger</surname>, <given-names>B. E.</given-names></string-name> <article-title>IPython: a System for Interactive Scientific Computing</article-title>. <source>Comput. Sci. Eng</source>. <volume>9</volume>, <fpage>21</fpage>&#x2013;<lpage>29</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Hunter</surname>, <given-names>J. D.</given-names></string-name> <article-title>Matplotlib: A 2D graphic environment</article-title>. <source>Comput. Sci. Eng</source>. <volume>9</volume>, <fpage>90</fpage>&#x2013;<lpage>95</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Pedregosa</surname>, <given-names>F.</given-names></string-name> &#x0026; <string-name><surname>Varoquaux</surname>, <given-names>G.</given-names></string-name> <article-title>Scikit-learn: Machine learning in Python</article-title>. <source>J. Mach. Learn</source>. <volume>12</volume>, <fpage>2825</fpage>&#x2013;<lpage>2830</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Humphrey</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Dalke</surname>, <given-names>A.</given-names></string-name> &#x0026; <string-name><surname>Schulten</surname>, <given-names>K.</given-names></string-name> <article-title>VMD: visual molecular dynamics</article-title>. <source>J. Mol. Graph</source>. <volume>14</volume>, <fpage>33-8</fpage>, <lpage>27-8</lpage> (<year>1996</year>).</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><given-names>Amitabh</given-names> <surname>Varshney</surname></string-name>, <string-name><given-names>Frederick P.</given-names> <surname>Brooks</surname>, <suffix>Jr.</suffix></string-name>, <string-name><suffix>Jr.</suffix> <surname>William</surname>, <given-names>W. V. W.</given-names></string-name> <article-title>Linearly Scalable Computation of Smooth Molecular Surfaces</article-title>. <source>IEEE Comput. Graph. Appl</source>. <volume>14</volume>, (<year>1994</year>).</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Frishman</surname>, <given-names>D.</given-names></string-name> &#x0026; <string-name><surname>Argos</surname>, <given-names>P.</given-names></string-name> <article-title>Knowledge-based protein secondary structure assignment</article-title>. <source>Proteins</source> <volume>23</volume>, <fpage>566</fpage>&#x2013;<lpage>79</lpage> (<year>1995</year>).</mixed-citation></ref>
</ref-list>
</back>
</article>
